| |
|
|
|
|
|
|
|||
|
Blood, Vol. 91 No. 3 (February 1), 1998:
pp. 968-976
By
From the Departments of Allergy and Clinical Immunology and
Experimental Medicine and Pathology, University of Rome "La
Sapienza," Rome; the Department of Dermatology, Catholic University
of Rome, Rome; the University of Sassari, Sassari; and the Laboratory
of Virology, Istituto Superiore di Sanità, Rome, Italy.
Evidence indicates that, at least in the early stage, Kaposi's
sarcoma (KS) is a cytokine-mediated disease and that it is consistently
associated with a novel herpesvirus termed human herpesvirus-8 (HHV-8).
To gain insights into the mechanisms by which cytokines and HHV-8 may
cooperate in disease pathogenesis, we examined the phenotype, the Th1
(
KAPOSI'S SARCOMA (KS) is an
angioproliferative disease involving the skin and mucosas that affects
elderly men of Mediterranean origin (classical KS, [C-KS]), as well
as transplantanted patients; it is endemic in Africa (endemic
KS),1-5 and it is the most common neoplasm of human
immunodeficiency virus type 1 (HIV-1) infected homo-bisexual men
(acquired immunodeficiency syndrome [AIDS]-KS).6,7 In
these patients, KS acquires a more aggressive course than C-KS. However, all of these forms have the same histopathology, including spindle-shaped cells, considered to be the tumor cells of KS, angiogenesis, inflammatory cell infiltration, and edema.1
The spindle-shaped cells are composed by an heterogeneous cell
population of endothelial cells with an activated cell phenotype,
macrophages, and dendritic cells.8,9
Recently, DNA sequences from a new virus called Kaposi-Sarcoma
herpesvirus or human herpesvirus-8 (HHV-8), have been found in the
majority of the lesions from patients with all forms of KS, and the
virus has been propagated from a KS skin lesion, suggesting an
epidemiologic association of the virus with KS,10-18
although its role in KS pathogenesis is yet unknown. HHV-8 has also
been found in peripheral blood mononuclear cell (PBMC) from these
patients, as well as in other pathologic conditions.19-21
Recent data also indicate that HHV-8 is persistently present in
circulating B cells22 and in blood-derived spindle-like
cells that are found in KS patients or in HIV-1-infected homosexual
men.23,24 In addition, productively infected mononuclear
cells including monocytes/macrophages25,26 and latently
infected endothelial and spindle cells27-29 are present in
KS lesions. The virus, however, is rapidly lost by cultured endothelial
spindle cells from KS lesions28,29 (and B.E., unpublished data, June 1995).
The immune system seems to play a major role in KS development. For
example, homosexual men, the group of HIV-1-infected individuals at
highest risk for KS, show increased signs of immunoactivation, including soluble CD8 and soluble intercellular adhesion molecule (ICAM) even before HIV-1 infection, and KS can represent the first sign
of AIDS.30-35 Recent studies indicate that KS itself
behaves as a cytokine-mediated disease, since the first observation
that conditioned media (CM) derived from retroviruses-infected
CD4+ T cells or CM from activated primary T cells or PBMC
(TCM), rich in tumor necrosis factor (TNF), KS-like cells with characteristics similar to endothelial and
macrophagic spindle cells derived from the lesions have also been found
in blood from KS patients with all forms of the
disease.23,24,45 Finally, the inflammatory cell
infiltration found in KS lesions, particularly in the early stage, is
associated with the production of the same inflammatory cytokines found
in TCM.42,46-49,49a TCM promote normal
endothelial cells to acquire the features of the KS cell phenotype,
including the responsiveness to the HIV-1 Tat molecule,37,49-51 that can increase the frequency and
aggressiveness of AIDS-KS.43
Despite this body of evidence for the involvement of the immune system
in KS development, little or nothing is known on the type of cells
infiltrating the lesions and on the Th1 and Th2 cytokine profile in
patients with KS and of its correlation with the presence of HHV-8.
Similarly, little or no information is currently available on the
effects of the cytokines increased in KS on tumor-infiltrating
lymphocytes (TIL) and spindle cells present in KS.
Th1 cytokines (IL-2 and In this study, we report that Patient population.
Eighteen patients affected by C-KS (men; mean age, 60 years) as well as
22 patients affected by AIDS-KS (21 men and one woman; mean age, 30 years; 18 homosexuals and four heterosexuals) were studied. Patients
with C-KS presented a cutaneous involvement only, whereas patients with
AIDS-KS presented a cutaneous and visceral (in 16 cases) involvement.
In all cases, the diagnosis of KS was supported by conventional
histology. A group of 20 normal volunteers was studied as control for
immunologic phenotyping of PBMC and a group of 34 patients affected by
skin disorders other than KS, such as psoriasis and chronic dermatitis,
were studied as control of cytokine production. All of the patients were free of cytokine therapy. Fourteen patients with HIV-1 infection were under antiretroviral therapy with AZT, whereas eight patients were
studied at the time of the first KS diagnosis and had refused any prior
antiretroviral therapy. Blood samples were obtained after written
informed consent.
Isolation of PBMC.
PB from patients was collected by venipuncture and heparinized (10 IU/mL, Liquemin, Hoffman-La Roche Co, Rome, Italy). PBMC were separated
by a Ficoll-Hypaque (Pharmacia, Uppsala, Sweden) gradient. Cells were
washed twice in Hanks' balanced salt solution, resuspended in RPMI
1640 (GIBCO Laboratories, Grand Island, NY) containing 20% fetal calf
serum (FCS) (GIBCO) and plated at a concentration of 106
cells/mL in 24-well plates (Falcon, Becton Dickinson, Lincoln Park,
NJ). Cells were stimulated with phytohemagglutinin (PHA) (PHA-L, Sigma Chemical, St Louis, MO) at a final dilution of 1 µm/mL
for 72 hours at 37°C to assess cytokine production. Control cultures consisted of PBMC plated in the presence of medium alone.
Cultures from KS skin biopsies.
Punch biopsies were performed at the site of cutaneous KS lesions and
at the site of apparently uninvolved skin after obtaining from the
patients a written informed consent to the biopsy. Tissues were
mechanically minced, fragments were washed in medium, and the released
lymphoid cells (TIL) were recovered and phenotyped immediately (day 0).
The tissue fragments were then cultured in gelatin-coated flasks (1.5%
final dilution of gelatin; bovine skin albumin, Sigma) with a culture
medium previously used to culture KS spindle cells from the
lesions.37 Growth medium consisted of RPMI 1640 medium
supplemented with 20% FCS, 1% Nutridoma-HU (100× solution)
(Boehringer Mannheim, Milan, Italy), 1% nonessential amino acids
(100× solution) (Sigma), 1 mmol/L sodium pyruvate (Sigma), 100 U/mL penicillin G-sodium and 100 mg/mL streptomycin sulfate (Sigma) and
20% CM prepared as described previously from normal donors' PBMC
after stimulation with PHA-L for 72 hours (TCM).37,49 A
bulk stock of TCM was prepared and used for all of the cultures. TCM
contained 96,551 pg/mL of IL-2, 841 pg/mL of Cell flow cytometry.
For double and triple fluorescence analysis, 2 × 105 cells (PBMC or TIL) were examined after staining with
the appropriate amounts of monoclonal antibodies (MoAbs) (20 µL of
phycoerythrin [PE], fluorescein isothiocyanate [FITC], or peridinin
chlorophyle protein [per CP]-conjugated) for 30 minutes on ice. After
two washings, cells were resuspended in phosphate-buffered saline (PBS)
and analyzed by flow cytometry (Cytoron, Ortho Diagnostics, Raritan,
NJ) after electronic gating on lymphocytes. The following MoAbs were
used: PE-conjugated CD8, PerCP-conjugated CD4, FITC-conjugated TCR Immunohistochemistry.
Immunohistochemical analyses were performed on adherent cells obtained
after 4 weeks of culture in TCM. Cells were detached by ice-cold
trypsin-EDTA (GIBCO), as per manufacturer's protocol, resuspended in
RPMI 1640, at a concentration of 2 × 106 and then
cytocentrifuged smears were made. These were incubated with the
following MoAbs: CD68 (Dakopatts, Dako, Golstrup, Denmark), LeuM3
(anti-CD14, Becton-Dickinson), OKT4 (anti-CD4, Ortho), OKT8 (anti-CD8,
Ortho), Leu11 (anti-CD16, Becton-Dickinson), CD19 (anti-B, Dakopatts),
anti-CD45 (Dakopatts), 11C81 (ICAM-1, British Biotechnology), HLA-DR
(Dakopatts), vWF/FVIII-RA (Dakopatts). The sections were then treated
with a biotin-conjugated horse anti-mouse Ig MoAbs and later with
avidin-biotin peroxidase complex (Vector Laboratories, Burlingame, CA)
and with 0.06% 3,3 Cytokine measurement.
Cytokines were measured on supernatants from PHA-stimulated PBMC or
skin cultures by enzyme-linked immunosorbent assay (ELISA) using
manifacturer's protocol (R&D Systems, Minneapolis, MN).
Detection of HHV-8 nucleic acid sequences.
Total DNA was extracted with a Microturbogen DNA extraction kit
(Invitrogen, San Diego, CA) from skin specimens as well as from
cultures derived from KS skin lesions or uninvolved skin cultured for a
period of 4 weeks. Some PBMC samples were also examined. A total of 100 ng of DNA was then amplified for HHV-8 nucleic acid sequences by nested
PCR by using as primers KS4 and KS5 for the first round of
amplification, followed by a second round with the primers KS1 and KS2,
previously described.10 Amplification was performed as
follows: 94°C for 3 minutes (1 cycle); 94°C for 1 minute,
58°C for 1 minute, 72°C for 1 minute (35 cycles); 72°C for
5 minutes (1 cycle). Each PCR reaction was performed with 50 pmol of
each primer, 1 U of Taq polymerase (Perkin-Elmer, Branchburg, NJ), 200 µmol/L of each deoxyribonucleotide triphosphates (dATP, dTTP, dGTP,
dCTP), Perkin-Elmer buffer 1×, 1.5 mmol/L MgCl2, in a
final volume of 50 µL. Amplifications were performed with a
Perkin-Elmer 9600 Thermocycler. PCR products were analyzed by Southern
blot hybridization using the HHV-8 specific probe KS330Bam 32P-end-labeled.10 Hybridization was performed
at 65°C. The positive control was the DNA extracted from a KS skin
biopsy and the negative control was DNA extracted from PBMC previously
known to be negative for HHV-8 DNA sequences.
Statistical analysis.
Analysis of variance was performed by the ANOVA test. A multiple
comparison of variance was performed by the Newman-Keuls test.
Clinical features of KS patients.
The main clinical features of patients with C-KS and AIDS-KS, as well
as data from healthy controls are reported in
Table 1. Most of the patients with KS were
men. Patients with C-KS were middle- or late-aged in comparison to
AIDS-KS patients and presented no risk factors for HIV-1 infection. The
majority of AIDS-KS patients were male homosexuals, with occasional
experience of intravenous drug use. Healthy controls had no risk
factors for HIV-1 infection.
Immmunological analysis of PBMC and TIL from KS patients: Local
infiltration of T-cell receptor
(TCR)
Immunohistochemical analysis of KS-derived spindle cells: Adherent
cells bear markers of the macrophage lineage.
The adherent cells derived from the skin lesions were grown for 4 weeks
in the presence or absence of TCM. These cells acquired a
spindle-shaped morphology (Fig 1) and the large majority of them was
strongly positive for CD68, HLA-DR, and ICAM-1
(Fig 3), but negative for markers of
leukocyte/lymphoid origin, including CD45, CD4, and CD8 (data not
shown). The endothelial cell marker vWF/FVIII-related antigen was low
or undetectable (data not shown). Thus, the growth conditions allowed
the expansion of spindle cells with an immunophenotype of tissue
macrophages. Uninvolved skin did not show the appearance of significant
amounts of these cells.
Cytokine profile: The majority of KS patients preferentially release
HHV-8 is detected in PBMC, lesions, and in spindle-like macrophagic
cell cultures of lesional skin from KS patients.
Because among all of the infectious agents proposed to play a role in
KS, HHV-8 appears to be the only one consistently associated, the
presence of HHV-8 DNA sequences was searched by nested PCR in our
experimental systems. Viral sequences were consistently detected in
100% (9/9) of the lesions from C-KS patients and in 100% (5/5) of the
lesions from AIDS-KS patients, as well as in 88% (8/9) and 66% (6/9)
of the PBMC from C-KS and AIDS-KS patients, respectively, but not in
the uninvolved skin far from the lesions (Table 4). Some perilesional skin was also
found to be positive. In addition, HHV-8 was detected in 88% (8/9) and
in 85% (6/7) 4-week-old adherent spindle cell cultures with a
macrophage phenotype derived from lesional skin of C-KS and AIDS-KS
patients, respectively and established in the presence of TCM
(Fig 4; Table 4).
Experimental observations have demonstrated a role of inflammatory and
angiogenic cytokines in KS development. These cytokines are increased
in KS lesions from both AIDS-KS and C-KS patients and stimulate the
growth of KS cells and the angiogenesis found in
KS.36-44,46-49
Submitted May 20, 1997;
accepted September 26, 1997.
We thank Dr G. Barillari (Department of Experimental Medicine,
University of "Tor Vergata," Rome, Italy) and Dr Paolo Monini (Laboratory of Virology, Isituto Superiore di Sanità, Rome,
Italy) for helpful discussion and A. Lippa for editorial assistance.
1.
Kaposi M:
Idiopatisches multiples Pigmensarkom der Haut.
Arch Dermatol Syph
4:265,
1872
2.
Safai B,
Good RA:
Kaposi's sarcoma: A review and recent developments.
Clin Bull
10:62,
1980[Medline]
[Order article via Infotrieve]
3.
Loethe F:
Kaposi's sarcoma in Ugandan Africans.
Acta Pathol Mic Sc Suppl
161:1,
1963
4.
Beral V:
Epidemiology of Kaposi's sarcoma.
Cancer Surv
10:5,
1991[Medline]
[Order article via Infotrieve]
5.
Penn I:
Kaposi's sarcoma in organ transplant recipients: Report of 20 cases.
Transplantation
27:8,
1979[Medline]
[Order article via Infotrieve]
6.
Gottlieb GJ,
Ackerman AB:
Kaposi's sarcoma: An extensively disseminated form in young homosexual men.
Hum Pathol
13:882,
1982[Medline]
[Order article via Infotrieve]
7.
Havercos HW,
Drotman DP,
Morgan M:
Prevalence of Kaposi's sarcoma among patients with AIDS.
N Engl J Med
312:1518,
1985[Medline]
[Order article via Infotrieve]
8.
Rutgers JL,
Wieczorek R,
Bonetti F,
Kaplan KL,
Posnett DN,
Friedman-Kien AE,
Knowles DM:
The expression of endothelial cell surface antigens by AIDS-associated Kaposi's sarcoma. Evidence for a vascular endothelial cell origin.
Am J Pathol
122:493,
1986[Abstract]
9.
Regezi JA,
MacPhail LA,
Daniels TE,
De Souza YG,
Greenspan JS,
Greenspan D:
Human immunodeficiency virus-associated oral Kaposi's sarcoma.
Am J Pathol
43:240,
1993
10.
Chang Y,
Ceserman E,
Pessin MS,
Lee F,
Culpepper J,
Knowles DM,
Moore PS:
Identification of Herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma.
Science
266:1865,
1994
11.
Moore PS,
Chang Y:
Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection.
N Engl J Med
332:1181,
1996
12.
Huang YQ,
Li JJ,
Kaplan MH,
Poiesz B,
Katabira E,
Zhang WC,
Feiner D,
Friedman-Kien AE:
Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma.
Lancet
345:759,
1995[Medline]
[Order article via Infotrieve]
13.
Dupin N,
Grandadam M,
Calvez V,
Gorin I,
Aubin JT,
Havard S,
Lamy F,
Leibowitch M,
Huraux JM,
Escande JP,
Agut H:
Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma.
Lancet
345:761,
1995[Medline]
[Order article via Infotrieve]
14.
Boshoff C,
Whitby D,
Hatzioannou T,
Fisher C,
van der Walt J,
Hatzakis J,
Weiss R,
Schulz T:
Kaposi's sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma.
Lancet
345:1043,
1995[Medline]
[Order article via Infotrieve]
15.
Miller G,
Rigsby MO,
Heston L,
Grogan E,
Sun R,
Metroka C,
Levy JA,
Gao S-J,
Chang Y,
Moore P:
Antibodies to butyrate-inducible antigens of Kaposi's sarcoma associated herpesvirus in patients with HIV-1 infection.
N Engl J Med
334:1292,
1996
16.
Lennette E,
Blackbourn DJ,
Levy JA:
Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients.
Lancet
348:858,
1996[Medline]
[Order article via Infotrieve]
17.
Uccini S,
Pilozzi E,
Stoppaccaiaro A,
Angeloni A,
Santarelli R,
Faggioni A,
Baroni CD,
Ruco LP,
Sirianni MC,
Vincenzi L,
Cerimele D,
Masala MV,
Cottoni F:
Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 is not detectable in peripheral blood mononuclear cells of the relatives of sporadic KS patients.
J Invest Dermatol
108:119,
1997[Medline]
[Order article via Infotrieve]
18.
Foreman KE,
Friborg J,
Kong W-R,
Woffendin C,
Polverini PJ,
Nickoloff BJ,
Nabel GJ:
Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma.
N Engl J Med
336:163,
1997
19.
Whitby D,
Howard MR,
Tenant-Flowers M,
Brink NS,
Copas A,
Boshoff C,
Hatzioannou T,
Suggett FEA,
Aldam DM,
Denton AS,
Miller RF,
Weller IVD,
Weiss RA,
Tedder RS,
Schulz TF:
Detection of Kaposi's sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma.
Lancet
346:799,
1995[Medline]
[Order article via Infotrieve]
20.
Cesarman E,
Chang Y,
Moore PS,
Said JW,
Knowles DM:
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.
N Engl J Med
332:1186,
1995
21.
Soulier J,
Grollet L,
Oksenhendler E,
Cacoub P,
Cazals-Hatem D,
Babinet P,
d'Agay MF,
Clauvel JP,
Raphael M,
Degos L,
Sigaux F:
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castelman's disease.
Blood
86:1276,
1995
22.
Ambroziak JA,
Blackbourn DJ,
Herndier BG,
Glogau RG,
Gullett JH,
McDonald AR,
Lennette ET,
Levy JA:
Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients.
Science
268:582,
1995
23.
Browning PJ,
Sechler JMG,
Kaplan M,
Washington RH,
Gendelman R,
Yarchoan R,
Ensoli B,
Gallo RC:
Identification and culture of Kaposi's sarcoma-like spindle cells from pheripheral blood of HIV-1 infected individuals and normal controls.
Blood
84:2711,
1994
24.
Sirianni MC,
Uccini S,
Angeloni A,
Faggioni A,
Cottoni F,
Ensoli B:
Circulating spindle cells: Correlation with human herpesvirus-8 (HHV-8) infection and Kaposi's sarcoma.
Lancet
349:255,
1997[Medline]
[Order article via Infotrieve]
25.
Blasig C,
Zietz C,
Haar B,
Neipel F,
Esser S,
Brockmeyer NH,
Tschachler E,
Colombini S,
Ensoli B,
Stürzl M:
Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus-8.
J Virol
10:7663,
1997
26.
Orenstein JM,
Alkan S,
Blauvelt A,
Jeang K-T,
Weinstein MD,
Ganem D,
Herndier B:
Visualization of human herpesvirus type 8 in Kaposi's sarcoma by light and transmission electron microscopy.
AIDS
11:35,
1997
27.
Zhong W,
Wang H,
Herndier B,
Ganem D:
Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma.
Proc Natl Acad Sci USA
93:6641,
1996
28. Boshoff C, Acholz T, Kennedy MM, Graham AK, Fisher C, Thomas A,
Mcgee JO'D, Weiss RA, O'Leary J: Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med 1:1274, 1995
29.
Li JJ,
Huang YQ,
Cockerell CJ,
Friedman-Kien AE:
Localization of human herpes-like virus type 8 in vascular endothelial cells and perivascular spindle-shaped cells of Kaposi's sarcoma lesions by in situ hybridization.
Am J Pathol
148:1741,
1996[Abstract]
30.
Honda M,
Kitamura K,
Mizutani Y,
Oishi M,
Arai M,
Okura T,
Igarahi S,
Yasukawa K,
Hirano T,
Kishimoto Y,
Mitsuyasu R,
Chermann JC,
Tokugana T:
Quantitative analysis of serum IL-6 and its correlation with increased levels of serum IL-2R in HIV-1-induced disease.
J Immunol
145:4059,
1990[Abstract]
31. Lahdevirta J, Mauri CPJ, Teppo AM, Repo H: Elevated levels of
circulating cachectin/tumor necrosis factor in patients with acquired
immunodeficiency syndrome. Am J Med 85:289, 1988 |